1999 - ASM Lifetime Achievement Award, American Society for Microbiology
1993 - Fellow of the American Academy of Arts and Sciences
1990 - Fellow of the American Association for the Advancement of Science (AAAS)
1984 - Member of the National Academy of Sciences
1971 - Oswald Avery Award, Infectious Diseases Society of America
The scientist’s investigation covers issues in Immunology, Molecular biology, Antibody, Cancer research and Immunotoxin. His studies examine the connections between Immunology and genetics, as well as such issues in Breast cancer, with regards to Primary tumor and Oncology. He interconnects Cell, In vitro, Lymphokine, Immunoglobulin D and Surface Immunoglobulin in the investigation of issues within Molecular biology.
His research in Antibody intersects with topics in Receptor and Computational biology. Jonathan W. Uhr has researched Cancer research in several fields, including Cross reactions, Apoptosis, Monoclonal antibody and Effector. His Immunotoxin research incorporates elements of Anticorps monoclonal, Gastroenterology, myalgia, Toxicity and Lymphoma.
His primary areas of investigation include Molecular biology, Antibody, Immunology, Antigen and Cancer research. The Molecular biology study combines topics in areas such as Cell, Biochemistry, Secretion, Immunoglobulin D and Surface Immunoglobulin. His research integrates issues of Cell culture and In vitro in his study of Antibody.
His Immunology study frequently draws connections between related disciplines such as Cancer. In his work, Signal transduction is strongly intertwined with Apoptosis, which is a subfield of Cancer research. Jonathan W. Uhr has included themes like Oncology and Pathology in his Breast cancer study.
Cancer research, Circulating tumor cell, Cancer, Breast cancer and Immunology are his primary areas of study. His Cancer research study incorporates themes from Receptor tyrosine kinase and Cell biology. The various areas that Jonathan W. Uhr examines in his Circulating tumor cell study include Immunophenotyping, Oncology and Biomedical engineering.
His studies in Breast cancer integrate themes in fields like Primary tumor and Pathology. His Immunology course of study focuses on Cancer dormancy and Lymphoma, Apoptosis and Immune system. His work in Nucleic acid addresses subjects such as Molecular biology, which are connected to disciplines such as Receptor.
His scientific interests lie mostly in Circulating tumor cell, Immunology, Breast cancer, Primary tumor and Internal medicine. His Circulating tumor cell research includes themes of Antibody and Biomedical engineering. In his research on the topic of Antibody, Cancer cell is strongly related with Blood flow.
His Immunology research is multidisciplinary, incorporating elements of Cancer dormancy, Cancer research, Receptor tyrosine kinase and Trastuzumab. His Cancer research study integrates concerns from other disciplines, such as CD8, Antigen, Cell culture and Immunity. The concepts of his Internal medicine study are interwoven with issues in Oncology, Tumor cells and Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.
W. Jeffrey Allard;Jeri Matera;M. Craig Miller;Madeline Repollet.
Clinical Cancer Research (2004)
Circulating tumor cells in patients with breast cancer dormancy
Songdong Meng;Debasish Tripathy;Eugene P. Frenkel;Sanjay Shete.
Clinical Cancer Research (2004)
Detection and characterization of carcinoma cells in the blood
Emilian Racila;David Euhus;Arthur J. Weiss;Chandra Rao.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor.
Randolph Noelle;Peter H. Krammer;Junichi Ohara;Jonathan W. Uhr.
Proceedings of the National Academy of Sciences of the United States of America (1984)
HER-2 gene amplification can be acquired as breast cancer progresses.
Songdong Meng;Debasish Tripathy;Sanjay Shete;Raheela Ashfaq.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Redesigning nature's poisons to create anti-tumor reagents.
ES Vitetta;RJ Fulton;RD May;M Till.
Methods and reagents for the rapid and efficient isolation of circulating cancer cells
Leon W. M. M. Terstappen;Galla Chandra Rao;Jonathan W. Uhr;Emilian V. Racila.
Microchip-based immunomagnetic detection of circulating tumor cells
Kazunori Hoshino;Yu Yen Huang;Nancy Lane;Michael Huebschman.
Lab on a Chip (2011)
Ellen S. Vitetta;Jonathan W. Uhr.
Phase I immunotoxin trial in patients with B-cell lymphoma.
Ellen S. Vitetta;Marvin Stone;Peter Amlot;Joseph Fay.
Cancer Research (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: